IBIO CIK: 1420720

iBio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
millions USD
FY22:
2.17
FY23:
–
FY24:
–
FY25:
–
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−29.4
FY23:
−29.3
FY24:
−16.6
FY25:
−18.6
FY26:
−35.1
(positive)
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−27.8
FY24:
−15.0
FY25:
−17.0
FY26:
–
(positive)
Change from FY23 to FY26
millions USD
FY22:
–
FY23:
−29.3
FY24:
−15.4
FY25:
−18.4
FY26:
−33.0
(positive)
Change from FY22 to FY26
millions USD
FY22:
−50.3
FY23:
−65.0
FY24:
−24.9
FY25:
−18.4
FY26:
−33.0

All amounts in millions USD Data sources:SEC EDGARTwelve Data